Skip to main content
Loading
Lihua Zheng

Lihua Zheng, JD, PhD

Co-Founder and CEO, Z-Star Therapeutics Inc.
Dr. Lihua Zheng is a successful serial entrepreneur and biotech executive. He is currently co-founder and CEO of Z-Star Therapeutics Inc., a New York City-based biotech company developing the next generation oncology and immunology therapeutics. Previously he co-founded AnHeart Therapeutics in 2018 as its Board Director and Chief Business/Strategy Officer responsible for business development, financing, legal and US operation. He led the successful in-licensing of three clinical-stage oncology assets from Daiichi Sankyo. He also led the successful out-licensing of commercial rights separately to Nippon Kayaku (TSE:4272), Innovent Biologics (XHKG: 1801) and NewG labs with upfront and milestone payments totaling more than $300 million plus double-digit royalties. He further led the private financings and raised more than $100 million before AnHeart was merged into Nuvation Bio (NYSE: NUVB) in Q1 2024. Lihua was an experienced transactional attorney at an international law firm Proskauer before he co-founded at a boutique law firm in New York City. He received his J.D. from Fordham University School of Law and a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine. He obtained his Masters and Bachelor of Science degree from Fudan University.
Sessions

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS